loading

Our Vision

Re-defining
Medicine for the Coming
Generation

Curing incurable diseases by re-programming cell fate or function.

Passionate

Reliable

Achievers

Committed

Team players

Innovative

Courageous

Engaged

Values in PRACTICE

iRegene's
mission

We are a passionate team committed
to developing first-in-class therapies
for patients suffering from major
incurable diseases. Making fast-acting
and disease-reversing therapies accessible
to patients in the greatest extent
possible is our priority.

P

Passionate

A

Achievers

T

Team players

C

Courageous

Reliable

R

Committed

C

Innovative

I

Engaged

E

Next Generation R&D Eco-system, Made by iRegene

iReMeta

Discovering Omics, Powered by AI

iReChem

Deep Learning Assisted Virtual Screening

iReXam

Compounds Validation

iReDita

Gene Editing & Reporter Cell Lines

iReCena

Designing Exosomes for Therapeutics Delivery

Independent Pipelines & Cooperation Pipelines

Project

Indication

POC Pre-Clinical IND Phase I

Phase II Phase III

RIGHT

NouvNeu001

Parkinson′s Disease

2023 H2 Initiate Clinical Trials

NouvNeu003*

Early-onset Parkinson's

2024 H2 Initiate Clinical Trials

NouvNeu002*

Ischemic Stroke

2024 H2 IND

NouvSight001

Retinal Degenerative Diseases

NouvHepa001

Liver Diseases

Contact

Wuhan Suzhou Denmark Singapore

iReMeta

Discovery Platform with the aid of AI Algorithms

• Omic analysis
• Information Learned from Patients
• Precise and distinctive models

Wuhan

Address

No. 9, Gaokeyuan 3rd Road, East Lake High-tech Development Zone, Wuhan

Tel.

(+86) 027-65522933 (+86) 027-59338180

Email

iregene@iregene.com

Suzhou

Address

218 Sang Tian Rd. BLDG 2 Rm.501 BioBAY Phase 2, Su Zhou Industrial Park Su Zhou, Jiang Su Province, 215000, China

Tel.

(+86) 186-9612-5803

Email

iregene@iregene.com

Denmark

Address

8000 Aarhus C, Denmark

Email

iregene@iregene.com

Singapore

Address

160 Robinson Road,#14-04 Singapore Business Federation Centre – Singapore 068914

Email

iregene@iregene.com